These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 16122413)

  • 21. Somatostatin receptor imaging in patients with neuroendocrine tumors: preoperative and postoperative scintigraphy and intraoperative use of a scintillation detector.
    Ahlman H; Tisell LE; Wängberg B; Nilsson O; Forssell-Aronsson E; Fjälling M
    Semin Oncol; 1994 Oct; 21(5 Suppl 13):21-8. PubMed ID: 7992076
    [No Abstract]   [Full Text] [Related]  

  • 22. 64Cu-TETA-octreotide as a PET imaging agent for patients with neuroendocrine tumors.
    Anderson CJ; Dehdashti F; Cutler PD; Schwarz SW; Laforest R; Bass LA; Lewis JS; McCarthy DW
    J Nucl Med; 2001 Feb; 42(2):213-21. PubMed ID: 11216519
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Somatostatin receptor scintigraphy. When would a SPECT study be performed?].
    Banzo J; Abós MD; García S; Prats E; Razola P; Alonso V; García F; Ubieto MA
    Rev Esp Med Nucl; 2003; 22(2):68-75. PubMed ID: 12646094
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Vasoactive intestinal peptide and somatostatin receptor scintigraphy for differential diagnosis of hepatic carcinoid metastasis.
    Kurtaran A; Raderer M; Müller C; Prokesch R; Kaserer K; Eibenberger K; Koperna K; Niederle B; Virgolini I
    J Nucl Med; 1997 Jun; 38(6):880-1. PubMed ID: 9189133
    [TBL] [Abstract][Full Text] [Related]  

  • 25. False-negative fluorine-18-FDG PET in metastatic carcinoid.
    Jadvar H; Segall GM
    J Nucl Med; 1997 Sep; 38(9):1382-3. PubMed ID: 9293792
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Somatostatin-receptor scintigraphy in gastroenteropancreatic tumors. An overview of European results.
    Krenning EP; Kwekkeboom DJ; Oei HY; de Jong RJ; Dop FJ; Reubi JC; Lamberts SW
    Ann N Y Acad Sci; 1994 Sep; 733():416-24. PubMed ID: 7978890
    [No Abstract]   [Full Text] [Related]  

  • 27. Factor analysis of dynamic series (FADS) in somatostatin receptor imaging.
    Kolesnikov-Gauthier H; Huglo D; Nocaudie M; Marchandise X
    J Nucl Med; 1999 Jan; 40(1):33-9. PubMed ID: 9935053
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Use of somatostatin receptor scintigraphy to image extrahepatic metastases of neuroendocrine tumors.
    Frilling A; Malago M; Martin H; Broelsch CE
    Surgery; 1998 Dec; 124(6):1000-4. PubMed ID: 9854575
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Imaging of somatostatin receptors in gastroenteropancreatic neuroendocrine tumors].
    Mure A; Lebtahi R; de Labriolle-Vaylet C; Askienazy S
    Gastroenterol Clin Biol; 1998 Oct; 22(10):809-18. PubMed ID: 9854206
    [No Abstract]   [Full Text] [Related]  

  • 30. Experience with somatostatin receptor scintigraphy in the management of pulmonary carcinoid tumors.
    Yellin A; Zwas ST; Rozenman J; Simansky DA; Goshen E
    Isr Med Assoc J; 2005 Nov; 7(11):712-6. PubMed ID: 16308994
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Somatostatin-receptor imaging of neuroendocrine gastroenteropancreatic tumors.
    Scherübl H; Bäder M; Fett U; Hamm B; Schmidt-Gayk H; Koppenhagen K; Dop FJ; Riecken EO; Wiedenmann B
    Gastroenterology; 1993 Dec; 105(6):1705-9. PubMed ID: 7902821
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Diagnosis, staging and follow-up of neuroendocrine tumors: role of somatostatin receptors scintigraphy].
    Lebtahi R
    Ann Pathol; 2011 Nov; 31(5 Suppl):S83-4. PubMed ID: 22054471
    [No Abstract]   [Full Text] [Related]  

  • 33. Positron-emission tomography as a radiological technique in neuroendocrine gastrointestinal tumors.
    Eriksson B; Lilja A; Ahlström H; Bjurling P; Bergström M; Lindner KJ; Långström B; Oberg K
    Ann N Y Acad Sci; 1994 Sep; 733():446-52. PubMed ID: 7978893
    [No Abstract]   [Full Text] [Related]  

  • 34. [Somatostatin receptor scintigraphy in neuroendocrine tumors exemplified by a patient with hepatic metastases of gastrinoma].
    Behr T; Becker W; Koch W; Grebmeier J; Wolf F
    Z Gastroenterol; 1994 Feb; 32(2):100-4. PubMed ID: 7513113
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Somatostatin receptor scintigraphy in pediatric bronchial carcinoid tumor].
    Hervás Benito I; Bello Arques P; Loaiza JL; Vercher JL; Velasco RP; Rivas Sánchez A; Ruiz Llorca C; Martí Vidal JF; Mateo Navarro A
    Rev Esp Med Nucl; 2010; 29(1):25-8. PubMed ID: 19819594
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Somatostatin receptor scintigraphy in preoperative diagnosis of the site of endocrine gastrointestinal tumors].
    Weinel RJ; Kisker O; Joseph K; Welcke U; Zaraca F; Rothmund M
    Chirurg; 1994 Oct; 65(10):849-55. PubMed ID: 7821043
    [TBL] [Abstract][Full Text] [Related]  

  • 37. 111In-octreotide scintigraphy in endocrine tumors. Preliminary data.
    Cremonini N; Furno A; Sforza A; Chiarini V; Graziano E; Zampa G; Turba E
    Q J Nucl Med; 1995 Dec; 39(4 Suppl 1):116-20. PubMed ID: 9002767
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Bone lesion in a patient with transplanted liver for a metastatic carcinoid. The role of somatostatin receptor scintigraphy.
    Savelli G; Chiti A; Spinelli A; Regalia E; Mazzaferro V; Castellani MR; Balzarini L; Musumeci R; Bombardieri E
    Tumori; 1998; 84(1):82-4. PubMed ID: 9619722
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Isotopic scan with somatostatin receptors in a case of recurrent carcinoid tumor. Relevance of tomographic detection].
    Bernà Roqueta L; Martín Marimón JC; Martín Martínez J
    Rev Esp Med Nucl; 2002 Apr; 21(2):123-4. PubMed ID: 11879622
    [No Abstract]   [Full Text] [Related]  

  • 40. Primary renal carcinoid tumor with liver metastases detected with somatostatin receptor imaging.
    Mufarrij P; Varkarakis IM; Studeman KD; Jarrett TW
    Urology; 2005 May; 65(5):1002. PubMed ID: 15882749
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.